<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Biochemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/257C5108-1625-44DA-8C36-1FBC1CEF564E"><gtr:id>257C5108-1625-44DA-8C36-1FBC1CEF564E</gtr:id><gtr:name>King's College Hospital Charitable Trust</gtr:name><gtr:address><gtr:line1>King's College Hospital</gtr:line1><gtr:line2>Denamark Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SE8 9RS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/9A9B0600-0FCE-488D-A3EC-16B407550744"><gtr:id>9A9B0600-0FCE-488D-A3EC-16B407550744</gtr:id><gtr:firstName>Thomas</gtr:firstName><gtr:otherNames>Calvert</gtr:otherNames><gtr:surname>Booth</gtr:surname><gtr:orcidId>0000-0003-0984-3998</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G1000265"><gtr:id>69768991-2FB2-4B37-8C52-448BE065C474</gtr:id><gtr:title>New imaging methods for detecting brain tumour response to treatment</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G1000265</gtr:grantReference><gtr:abstractText>Patients with similar tumour types frequently have markedly different responses to the same
therapy. The development of new treatments would benefit, therefore, from the introduction of imaging methods that allow an early assessment of treatment response, allowing rapid selection of the most effective treatment, with welfare benefits for the patient and cost benefits for the healthcare system. Beneficial responses to treatment are still largely assessed from imaging measurements of reductions in tumour size. However, this may take several weeks to become manifest. 

Time is critical in the common brain tumour, glioblastoma multiforme, where the chance of being alive after 2 years is 16%. The aim of this research project is to develop imaging methods, which could be used in a hospital setting to detect the early responses of brain tumours to therapy. Firstly, by using a novel magnetic resonance (MR) method that detects a beneficial response to treatment through changes in chemical reactions within tumours. Secondly, by a novel image processing method in which a beneficial response to treatment is detected through changes in the wholeness of images. Here, MR images from patients are assessed.

A radiologist will perform the research under the guidance of an experienced research imaging scientist.</gtr:abstractText><gtr:technicalSummary>Aim 
The aim of this research project is to develop non-invasive and clinically applicable imaging methods for detecting the early responses of brain tumours to therapy. Firstly, by using a novel magnetic resonance (MR) method that increases sensitivity in the MR experiment by &amp;gt;10,000x and which detects treatment response in rodent models through specific changes in tumour metabolism. Secondly, by a novel image processing method in which treatment response is detected through changes in image heterogeneity. Here, clinical MR images will be assessed.

Objectives
Objectives for the hyperpolarizer experiments are, using rat glioblastoma multiforme (GBM) controls and cases pre- and 1-5 days post-treatment (an alkylating cytotoxic, a tyrosine kinase inhibitor, a PI3K-akt-mTOR inhibitor, an anti-angiogenic) to measure [1-13C]lactate levels and lactate dehydrogenase catalyzed flux from [1-13C]pyruvate; [1,4-13C2]malate levels and fumarase catalyzed flux from [1, 4-13C2]fumarate; extracellular pH from H13CO3-.

The objective for the image analysis project is to develop and evaluate Minkowski Functional analysis for detecting treatment response in a clinical dataset acquired from patients with GBM treated with radiotherapy and concomitant and adjuvant temozolomide - in particular to differentiate pseudoprogression from true progression.

Design
MATLAB software will be used to segment and perform Minkowski Functional analysis on clinical MR images of patients with GBM.

Methodology
Cells will be cultured then implanted intracranially using stereotactic techniques. Syngeneic F98 cells will be implanted into Fischer rats and human GBM xenografts will be implanted into athymic rats. Hyperpolarized samples will be prepared using a Hypersense dynamic nuclear polarizer. Samples will be infused intravenously and MR spectroscopy will be used to measure the metabolites produced. Histopathology and immunohistochemistry will provide gold standard comparators for treatment response. Apoptosis and necrosis will be examined using TUNEL and haematoxylin and eosin. HIF-1, carbonic anhydrase IX, VEGF, CD31 and LDHA will be measured.

Scientific opportunities
Prof Brindle?s laboratories include histopathology, flow cytometry, genomics, microscopy, transgenic rodent facilities and imaging. The latter includes fluorescent and bioluminescent imaging, high field MRI machines, Hypersense and prototype DNP hyperpolarizers, high-resolution ultrasound and micro PET/SPECT/CT. The laboratories comprise 22 research staff and students. In a recent CRUK quinquennial laboratory review, work on hyperpolarized 13C was rated outstanding, as was his proposed polarizer work for the next 5 years.

Medical opportunities
Honorary contracts for the National Hospital for Neurology and Neurosurgery, London and Addenbrookes, Cambridge are arranged to allow attendance at neuroradiology clinical sessions and brain tumour multi-disciplinary meetings.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-08-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>171094</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Biochemistry department talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>95D7F6FB-3027-46CE-9E8E-15493A1C63B1</gtr:id><gtr:impact>Interactive discussion of research

Academics asked about my research thereafter</gtr:impact><gtr:outcomeId>54633a4faa7720.09504855</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Research Institute presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>FB41A60C-3C96-4FAD-82F2-726F627FAE84</gtr:id><gtr:impact>Questions and discussion followed in a formal setting

Academics asked about my research thereafter</gtr:impact><gtr:outcomeId>54633bc8149d38.69576737</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Molecular Imaging Seminar presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>43485CDA-F8BC-414E-A07B-8602492A0800</gtr:id><gtr:impact>Questions and discussion during the presentation

Academics asked about my research thereafter</gtr:impact><gtr:outcomeId>54633cee9ad435.29740532</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Cambridge Research Institute presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>DF7DB544-8FFC-4EE2-B3FE-EBF2BC9078FC</gtr:id><gtr:impact>Formal questions and discussion

Academics asked about my research thereafter</gtr:impact><gtr:outcomeId>54633c2bd3da76.29708867</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Other academic audiences (collaborators, peers etc.)</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Mayoress, Newspaper journalists discussion about cancer research</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>B837183C-5AA2-4084-8678-39B3725DE008</gtr:id><gtr:impact>Article in local press about research into cancer

Discussed locally</gtr:impact><gtr:outcomeId>PjMAiGeDabr</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Hospital presentation and talk</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>AA54A5EA-6837-4D80-B16C-2007DA4427A2</gtr:id><gtr:impact>Very interactive discussion with audience of new research that can be applied to neuroradiology

Professional neuroradiologists asked for review articles to understand more about the research</gtr:impact><gtr:outcomeId>54633995ee4f97.29387952</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Professional Practitioners</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Biochemistry department poster presentation</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>7A8FF610-3EAC-4A9C-9141-0D4F6BE9419D</gtr:id><gtr:impact>Debate and discussion with academics asked about my research

Academics asked about my research thereafter</gtr:impact><gtr:outcomeId>54633b1cdbb150.56970603</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Postgraduate students</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Industry talk (with a view to encourage industry to charitably fund medical research)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>94DEBABE-CD5B-41A5-84C2-332C73A68BBD</gtr:id><gtr:impact>Presentations and informal talk sparked interest and discussion of translational medical research

Talk of funding of translational medical research</gtr:impact><gtr:outcomeId>5463385eed8d55.69075488</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Supporters</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Represented Cambridge Research Institute at Cambridge Science Festival (Cambridge)</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>6439406E-7856-449C-8EFA-A9F386B03268</gtr:id><gtr:impact>Hundreds of members of the public attended which spaarked questions on cancer and research

Some school children said they would pursue a career in science and/or medicine</gtr:impact><gtr:outcomeId>nnE5YQ5q8kq</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.cam.ac.uk/science-festival</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Laboratory presentations</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>32D350D6-803F-49FE-A036-FA33B849A6D3</gtr:id><gtr:impact>Discussion of research.

Changed research to make it more focused and relevant. Helped others develop concepts and collaborate.</gtr:impact><gtr:outcomeId>54633daf009794.45560746</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2009,2010,2011,2012,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>400</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>School of Clinical Medicine</gtr:department><gtr:description>EG Fearnsides Scholarship Award</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>A0744768-C40B-45D7-BC6F-A94CC6990CF4</gtr:id><gtr:outcomeId>ZtZjh6L5LPM</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Association of Cancer Research Student Award</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>British Association for Cancer Research (BACR)</gtr:fundingOrg><gtr:id>FD1623D1-298D-4290-9F9C-FD1049F6D905</gtr:id><gtr:outcomeId>CPNwVLr9Rov</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1416</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Early Career Award</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Cancer Research UK Cambridge Institute</gtr:fundingOrg><gtr:id>5F7477DE-3BB6-4C02-94ED-9416F51FC33B</gtr:id><gtr:outcomeId>EnJezxWD5wc</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>80</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Department of Biochemistry</gtr:department><gtr:description>Sanger Fund Award</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>University of Cambridge</gtr:fundingOrg><gtr:id>763CD0D6-0A19-4FBF-965D-3E460859B91B</gtr:id><gtr:outcomeId>ZgvbKcTQk9v</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cambridge Philosphical Society Travel Grant</gtr:description><gtr:end>2012-11-02</gtr:end><gtr:fundingOrg>Cambridge Philosophical Society</gtr:fundingOrg><gtr:id>DFD7A4CD-2D34-49B8-8984-DC1136BD0441</gtr:id><gtr:outcomeId>o2xoPBPeTKm</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>100</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Cambridge Philosophical Society Travel Grant</gtr:description><gtr:end>2011-09-02</gtr:end><gtr:fundingOrg>Cambridge Philosophical Society</gtr:fundingOrg><gtr:id>F965565E-F703-438F-B775-08B60ED75F86</gtr:id><gtr:outcomeId>S7M7nJE7AUx0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2011-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>34241</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Clinical Fellowship</gtr:description><gtr:end>2013-03-02</gtr:end><gtr:fundingOrg>Cancer Research UK Cambridge Institute</gtr:fundingOrg><gtr:fundingRef>28995</gtr:fundingRef><gtr:id>9C6BF7B0-9F05-40FB-8766-E9C2D1265B96</gtr:id><gtr:outcomeId>m6V4orW8XxU</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Addenbrookes Charitable Trust Cancer Research Fellowship Award</gtr:description><gtr:end>2011-08-02</gtr:end><gtr:fundingOrg>Addenbrooke's Charitable Trust (ACT)</gtr:fundingOrg><gtr:id>088B4498-CBBC-4072-B2D1-0769FA8E970A</gtr:id><gtr:outcomeId>QZfqqGgmg730</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2010-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Academic Committee member at Royal College of Radiologists</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A1C050FF-3BDC-4EF6-AA2D-3967524E7E58</gtr:id><gtr:impact>Research certificate created and examined enabling trainee radiologists to become research active; Policy on Brexit developed; Grant review</gtr:impact><gtr:outcomeId>56de12b48f7fa7.83791254</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Evaluation of two selection tests for recruitment into radiology specialty training</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>47D147F1-C26C-455C-AFF8-4B0818D8C166</gtr:id><gtr:impact>Evaluation of two selection tests for recruitment into radiology specialty training. Patterson F., Knight A., McKnight L.,&amp;nbsp;Booth T.C. BMC Med Educ. 2016 Jul 11;16(1):170. doi: 10.1186/s12909-016-0687-0.</gtr:impact><gtr:outcomeId>58c9452265e3c2.50035463</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Cancer Research Institute, Panel of Experts</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>E6EC8932-2222-4CA1-94E5-895DA5E18243</gtr:id><gtr:impact>review &amp;amp; advise</gtr:impact><gtr:outcomeId>56de12228836e1.00928850</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Radiology Research Strategy: Booth TC et al Clin Radiol 2012. 67(5): 4116</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>78263B1C-C20D-4A71-B807-A00E15BD0F33</gtr:id><gtr:impact>Devised a strategy to increase research in radiology. In particular, in radiology trainees - this was my main area of input. My lobbying for research opportunities for trainees lead to inclusion of research in the FRCR curriculum, an annual radiology research day (aimed at trainees) and ensured a database for radiology research mentors was set up with the RCR which was overseen by me personally.</gtr:impact><gtr:outcomeId>f5qTAUBZAMc</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Academic Committee member at Royal College of Radiologists (2016)</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>17C74FD7-23AD-439D-95D0-266857DC197B</gtr:id><gtr:impact>Research certificate created and examined enabling trainee radiologists to become research active
Policy on Brexit developed
Grant review</gtr:impact><gtr:outcomeId>58c943f10ff913.52369358</gtr:outcomeId><gtr:type>Membership of a guideline committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Trainee representative for Academic Committee RCR</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A4C3A699-4980-40B3-999C-DDCBAB6B1AED</gtr:id><gtr:impact>Devised a strategy to increase research in radiology. In particular, in radiology trainees - this was my main area of input. My lobbying for research opportunities for trainees lead to inclusion of research in the FRCR curriculum, an annual radiology research day (aimed at trainees) and ensured a database for radiology research mentors was set up with the RCR which was overseen by me personally.</gtr:impact><gtr:outcomeId>swJNjPK2veE</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Radiology in the undergraduate medical curriculum - who, how, what, when, and where? Clin Radiol 2012 Dec;67(12):1146-52</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>94F26A41-6D76-4D40-90B1-7C77DE3AE30C</gtr:id><gtr:impact>Published strategies to increase undergraduate understanding of radiology and anatomy.</gtr:impact><gtr:outcomeId>QWWgwKbY9og</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Post Brexit: Challenges and opportunities for radiology beyond the European Union</gtr:description><gtr:geographicReach>Europe</gtr:geographicReach><gtr:id>462967C9-B2A2-4331-BC19-3D1F7C8B572F</gtr:id><gtr:impact>Post Brexit: Challenges and opportunities for radiology beyond the European Union. Piorkowska M., Goh V., Booth T.C. Br J Radiol. 2017 Mar 10:20160852. doi: 10.1259/bjr.20160852. [Epub ahead of print]</gtr:impact><gtr:outcomeId>58c945ee534126.76299758</gtr:outcomeId><gtr:type>Implementation circular/rapid advice/letter to e.g. Ministry of Health</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>National Cancer Research Institute, Brain Tumour Subgroup, Imaging member. National Cancer Research Institute, Panel of Experts</gtr:description><gtr:geographicReach>National</gtr:geographicReach><gtr:id>A7091CFB-4397-490A-9C1C-49431310C97A</gtr:id><gtr:outcomeId>56de11e9472c93.04870767</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Imaging with hyperpolarized carbon allows treatment response assessment of brain tumours.

I have completed the PhD and am working at a site that does not have the infrastructure to support this.</gtr:description><gtr:id>36AF2047-6479-4B76-8507-2432A56579FA</gtr:id><gtr:impact>Very promising but too early to tell</gtr:impact><gtr:outcomeId>54637da397ca40.81610221</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>On hold</gtr:status><gtr:title>Hyperpolarized carbon allows treatment response assessment of brain tumours</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>The wokr has been completed and the hypotheses have been tested. Awaiting publication.</gtr:description><gtr:id>C04E4990-14B6-408F-B21E-28FE5C40DB8B</gtr:id><gtr:impact>This work will inform clinical trials of human glioblastoma.</gtr:impact><gtr:outcomeId>sjAxW9YvL9f</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>A DNP probe allows treatment response detection in brain tumours</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput><gtr:productOutput><gtr:description>Using Minkowski Functional image analysis of routinely obtained clinical retrospective T2w images, glioblastoma progression can be distinguished from pseudoprogression.</gtr:description><gtr:id>52498865-7C1D-4E87-A7F8-90892972274E</gtr:id><gtr:impact>Promising but too early to tell how this will impact in the future.</gtr:impact><gtr:outcomeId>pBmMVvLuKbt</gtr:outcomeId><gtr:stage>Early clinical assessment</gtr:stage><gtr:status>Under active development/distribution</gtr:status><gtr:title>Minkowski Functional image analysis of T2w images to distinguish glioblastoma progression from pseudoprogression</gtr:title><gtr:type>Diagnostic Tool - Imaging</gtr:type><gtr:yearDevCompleted>2013</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Minkowski Functionals used to be feature descriptors of heterogeneity in brain tumour treatment response. First time used for human MRI.</gtr:description><gtr:id>5CA12ADA-E680-4D5B-A02C-AB96EBD0639A</gtr:id><gtr:impact>Model and techniques will be published with open access.</gtr:impact><gtr:outcomeId>54639b6aa4b0c6.77610745</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Minkowski Functionals</gtr:title><gtr:type>Data analysis technique</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Reproducable F98 brain tumour model developed in Fischer rats</gtr:description><gtr:id>8045A329-79D5-4EB8-BE68-16F62716CB3B</gtr:id><gtr:impact>Will allow brain tumour imaging experiments</gtr:impact><gtr:outcomeId>soyC9zdERtX</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>F98 brain tumour model in Fischer rats</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Dynamic nulcear polarisation probes optimised
MR for these probes optimised</gtr:description><gtr:id>DCFED4DC-7889-4FE4-9C23-0B54F62A52BC</gtr:id><gtr:impact>Allowed experimental hypotheses to be tested</gtr:impact><gtr:outcomeId>PaNPL8kALBU</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Established dynamic nuclear polarisation protocol for in vivo brain tumour imaging experiments</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Established reproducible brain tumour model</gtr:description><gtr:id>200E17A2-B7F9-4305-844F-977B8831803A</gtr:id><gtr:impact>Allowed further molecular imaging research in laboratory</gtr:impact><gtr:outcomeId>V6mPS7mRMtY</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>C6 brain tumour model in Fischer rats</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Brain tumour imaging size weighting to aid image analysis</gtr:description><gtr:id>C4ADA4AC-D5F3-4C3D-8B83-D31DCB7A978D</gtr:id><gtr:impact>Makes image analysis more accurate</gtr:impact><gtr:outcomeId>ch6XAwLskr4</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Brain tumour imaging size weighting</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Establised brain tumour model</gtr:description><gtr:id>0435D092-F65A-410D-AA51-4F1C84EC4864</gtr:id><gtr:impact>Allowed further imaging experiments</gtr:impact><gtr:outcomeId>TvyQapyu1Sg</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>U87 brain tumour model in rnu/rnu rats</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Allows differentiation of brain tumour response using conventional MRI sequences</gtr:description><gtr:id>77E3FE18-6705-4C22-AFCB-630D74C9EBCC</gtr:id><gtr:impact>Too early to say</gtr:impact><gtr:outcomeId>FwuKWS5sAxk</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Feature select and classification of datasets</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>establishemnt of pKa for hyperpolarised 13C bicarbonate for cancer imaging. Will make Henderson-Hasslebalch pH calculations more accurate.</gtr:description><gtr:id>21CBFBAC-9868-42E9-8151-43021251958E</gtr:id><gtr:impact>Makes Henderson-Hasslebalch derived in vivo pH calculations more accurate.</gtr:impact><gtr:outcomeId>kwUpp2nwW9K</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Establishment of pKa for hyperpolarised 13C bicarbonate</gtr:title><gtr:type>Model of mechanisms or symptoms - in vitro</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Using collimation, a Cs-137 irradiator can deliver rodent radiotherapy</gtr:description><gtr:id>854435C6-47A0-460F-A894-6D41208B8C84</gtr:id><gtr:impact>Rodent radiotherapy will allow treatment response to be assessed with imaging</gtr:impact><gtr:outcomeId>UbhoGye8jSq</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Radiotherapy model for rodents</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>8028681C-453B-4515-8C8F-B22B29F6B376</gtr:id><gtr:title>Neuro-Oncology Single-Photon Emission CT: A Current Overview</gtr:title><gtr:parentPublicationTitle>Neurographics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/686fd78c1212b8813a3239a0bafe8425"><gtr:id>686fd78c1212b8813a3239a0bafe8425</gtr:id><gtr:otherNames>Booth T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>AhDigYx8Zai</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E2F02211-038E-42CC-BB93-31C2F7250736</gtr:id><gtr:title>Re: Tumour progression or&amp;nbsp;pseudoprogression? A&amp;nbsp;review of post-treatment radiological appearances of glioblastoma.</gtr:title><gtr:parentPublicationTitle>Clinical radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a25b67078cd6b07bcb5b10ba2f6c043f"><gtr:id>a25b67078cd6b07bcb5b10ba2f6c043f</gtr:id><gtr:otherNames>Booth TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-9260</gtr:issn><gtr:outcomeId>56de10208bc2d3.23859558</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BC8FBE39-87C3-4048-8B23-E1C0CD70EF61</gtr:id><gtr:title>Carbonic Anhydrase Activity Monitored In Vivo by Hyperpolarized 13C-Magnetic Resonance Spectroscopy Demonstrates Its Importance for pH Regulation in Tumors.</gtr:title><gtr:parentPublicationTitle>Cancer research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0fe2f2dd3e681c073ddf63ff39798cee"><gtr:id>0fe2f2dd3e681c073ddf63ff39798cee</gtr:id><gtr:otherNames>Gallagher FA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0008-5472</gtr:issn><gtr:outcomeId>56de102047f235.46154538</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1C2E32BD-EC2E-47B0-8555-BF6CB67E530F</gtr:id><gtr:title>Comment on &amp;quot;The role of imaging in the management of progressive glioblastoma. A systematic review and evidence-based clinical practice guideline&amp;quot; [J Neurooncol 2014; 118:435-460].</gtr:title><gtr:parentPublicationTitle>Journal of neuro-oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a25b67078cd6b07bcb5b10ba2f6c043f"><gtr:id>a25b67078cd6b07bcb5b10ba2f6c043f</gtr:id><gtr:otherNames>Booth TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0167-594X</gtr:issn><gtr:outcomeId>54633f7cb2cda2.92653993</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B89F6B4-3C99-4178-8851-D305D4165C98</gtr:id><gtr:title>Re: Bench to bedside molecular functional imaging in translational cancer medicine: to image or to imagine?</gtr:title><gtr:parentPublicationTitle>Clinical radiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a25b67078cd6b07bcb5b10ba2f6c043f"><gtr:id>a25b67078cd6b07bcb5b10ba2f6c043f</gtr:id><gtr:otherNames>Booth TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0009-9260</gtr:issn><gtr:outcomeId>56de1020aca4c2.08617796</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DD19DDE9-D128-4576-8010-8B638DB55644</gtr:id><gtr:title>Analysis of heterogeneity in T2-weighted MR images can differentiate pseudoprogression from progression in glioblastoma.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a25b67078cd6b07bcb5b10ba2f6c043f"><gtr:id>a25b67078cd6b07bcb5b10ba2f6c043f</gtr:id><gtr:otherNames>Booth TC</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5a2fd359a9c3b6.76817101</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1AA60B03-5666-42CF-8AFD-1C3801317840</gtr:id><gtr:title>Analysis of image heterogeneity using 2D Minkowski functionals detects tumor responses to treatment.</gtr:title><gtr:parentPublicationTitle>Magnetic resonance in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9424075dbe20c4dc501f344c932f7a8"><gtr:id>f9424075dbe20c4dc501f344c932f7a8</gtr:id><gtr:otherNames>Larkin TJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0740-3194</gtr:issn><gtr:outcomeId>pm_16419_29_23440731</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5FD7D1D-7CB9-46AF-9E00-028B3E97AB75</gtr:id><gtr:title>MINKOWSKI FUNCTIONAL IMAGE ANALYSIS ALLOWS PSEUDOPROGRESSION TO BE DIFFERENTIATED FROM PROGRESSION IN BRAIN TUMOURS</gtr:title><gtr:parentPublicationTitle>NEURO-ONCOLOGY</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/75f31a0c33a0466480152ff00612e463"><gtr:id>75f31a0c33a0466480152ff00612e463</gtr:id><gtr:otherNames>Booth T. C.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1522-8517</gtr:issn><gtr:outcomeId>Bji2entpDcz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C1EE9861-AC2C-4985-BEC6-899CD5E6C11C</gtr:id><gtr:title>Determination of the pKa of a hyperpolarized H13CO3- pH probe</gtr:title><gtr:parentPublicationTitle>Proc Intl Soc Mag Reson Med</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0a00763ff601b555cd199d583b8adf84"><gtr:id>0a00763ff601b555cd199d583b8adf84</gtr:id><gtr:otherNames>Booth Thomas</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:outcomeId>V8xzn8Ty96A</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000265</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>